Individualization of Controlled Ovarian Stimulation Using Anti-mullerian Hormone as a Biomarker of Ovarian Response Maximize the Beneficial Effects of Treatment and Minimize Complication and Risk.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Luteinising hormone; Recombinant follicle-stimulating hormone
- Indications Infertility
- Focus Biomarker; Therapeutic Use
- 26 Jun 2014 Biomarkers information updated
- 19 Aug 2013 New trial record